Drug Metabolism Reviews

Papers
(The H4-Index of Drug Metabolism Reviews is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Drug transporters in drug disposition – the year 2022 in review53
CYP24A1: the pivotal regulator of vitamin D homeostasis, pathophysiology in metabolic and genetic disease, and emerging target for precision medicine43
Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models41
Phase II metabolism in xenobiotic biotransformation: general mechanisms and the underestimated role of microbial systems35
Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids22
New strategy for rational use of antihypertensive drugs in clinical practice in high-altitude hypoxic environments22
An in-depth review of PPARγ modulators as anti-diabetes therapeutics20
Mechanisms of intestinal pharmacokinetic natural product-drug interactions18
A critical review of analytical tools for the detection of spironolactone and its metabolites17
Cytochrome P450-mediated carbon-carbon bond formation in drug metabolism16
Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations15
Multimolecular interactions from Chinese medicines activate nuclear receptor conformational changes: a potential strategy for anti-inflammatory therapy15
Redox enzyme networks shaping cancer drug metabolism and therapeutic resistance14
Biopolymers as promising vehicles for drug delivery to the brain13
0.10956001281738